Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?

被引：2
|
作者：
Drueeke, Tilman B. [1 ,2 ]
Floege, Juergen [3 ]
机构：
[1] Paris Sud Univ, Inserm U 1018, Ctr Rech Epidemiol & Sante Populat CESP, Paris lle de France Ouest Univ, Villejuif, France
[2] Paris Saclay Univ, Villejuif, France
[3] Rheinisch Westfalische Tech Hsch Aachen, Univ Hosp, Dept Nephrol & Clin Immunol, Aachen, Germany
来源：
KIDNEY INTERNATIONAL | 2021年 / 99卷 / 05期
关键词：
PTH;
D O I：
10.1016/j.kint.2021.01.019
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In chronic kidney disease, parathyroid hormone (PTH), like all proteins, can undergo post-translational modifications, including oxidation. This can lead to structural and functional changes of the hormone. It has been hypothesized that currently used PTH measurement methods do not adequately reflect PTH-related bone and cardiovascular abnormalities in chronic kidney disease owing to the presence of oxidized, biologically inactive PTH in the circulation. Ursem et al. now report a strong correlation between serum non-oxidized and total PTH, and comparable associations with histomorphometric and circulating bone turnover markers, pleading against this hypothesis.
引用
收藏
页码：1070 / 1072
页数：3
相关论文
共 50 条
  • [41] Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
    Lishmanov, Anton
    Dorairajan, Smrita
    Pak, Youngju
    Chaudhary, Kunal
    Chockalingam, Anand
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 541 - 547
  • [42] Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?
    Goodman, WG
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2005, 14 (04): : 355 - 360
  • [43] Misdiagnosis of chronic kidney disease and parathyroid hormone testing during the past 16 years
    Haojie Liu
    Huan Zhao
    Danna Zheng
    Wenfang He
    Yueming Liu
    Juan Jin
    Qiang He
    Bo Lin
    Scientific Reports, 13
  • [44] Misdiagnosis of chronic kidney disease and parathyroid hormone testing during the past 16 years
    Liu, Haojie
    Zhao, Huan
    Zheng, Danna
    He, Wenfang
    Liu, Yueming
    Jin, Juan
    He, Qiang
    Lin, Bo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] The effect of chronic kidney disease on intraoperative parathyroid hormone: A linear mixed model analysis
    Graves, Claire E.
    Hwang, Richard
    McManus, Catherine M.
    Lee, James A.
    Kuo, Jennifer H.
    SURGERY, 2021, 169 (05) : 1152 - 1157
  • [46] Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease
    Pipili, Chrysoula
    Dimitriadis, Chrysostomos
    Sekercioglu, Nigar
    Bargman, Joanne M.
    Oreopoulos, Dimitrios D.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (01) : 167 - 171
  • [47] A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease
    Moe, Sharon M.
    Saifullah, Akber
    LaClair, Robert E.
    Usman, Sohail A.
    Yu, Zhangsheng
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (02): : 299 - 306
  • [48] Clinical relevance and future perspective of fractures in patients with chronic kidney disease
    Fusaro, Maria
    Cannata-Andia, Jorge B.
    Nickolas, Thomas L.
    Plebani, Mario
    Mereu, Maria Cristina
    Aghi, Andrea
    Gallieni, Maurizio
    KIDNEY INTERNATIONAL, 2018, 93 (05) : 1248 - 1248
  • [49] Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
    Neumann, J
    Ligtenberg, G
    Klein, II
    Koomans, HA
    Blankestijn, PJ
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1568 - 1576
  • [50] Enhancing Clinical Relevance in the Management of Chronic Kidney Disease in Dialysis Patients
    Zhang, Yuqian
    Chang, Qianqian
    JOURNAL OF CLINICAL NURSING, 2024,
12345